Carregant...
Candidate drug replacements for quinacrine in cutaneous lupus erythematosus
Cutaneous lupus erythematosus (CLE) is a disfiguring and potentially disabling disease that causes significant morbidity in patients. Antimalarials are an important class of medication used to treat this disease and have been the first-line systemic therapy since the 1950s. Quinacrine, in particular...
Guardat en:
| Publicat a: | Lupus Sci Med |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7577055/ https://ncbi.nlm.nih.gov/pubmed/33082164 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/lupus-2020-000430 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|